Is the fluoroquinolone combination necessary for empirical antibiotic regimen in severe community-acquired pneumonia?

CONCLUSION: In patients with severe CAP, there were no differences in the clinical outcomes, including mortality, between the TZP and FQ combination therapy and TZP monotherapy. FQ combination was not significantly associated with in-hospital mortality.PMID:38658366 | DOI:10.1080/00325481.2024.2347830
Source: Postgraduate Medicine - Category: Internal Medicine Authors: Source Type: research